Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Current Deferred Revenue (2019 - 2025)

Historic Current Deferred Revenue for Outset Medical (OM) over the last 7 years, with Q4 2025 value amounting to $13.8 million.

  • Outset Medical's Current Deferred Revenue rose 817.06% to $13.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.8 million, marking a year-over-year increase of 817.06%. This contributed to the annual value of $13.8 million for FY2025, which is 817.06% up from last year.
  • As of Q4 2025, Outset Medical's Current Deferred Revenue stood at $13.8 million, which was up 817.06% from $14.9 million recorded in Q3 2025.
  • In the past 5 years, Outset Medical's Current Deferred Revenue ranged from a high of $14.9 million in Q3 2025 and a low of $3.5 million during Q1 2021
  • For the 5-year period, Outset Medical's Current Deferred Revenue averaged around $10.0 million, with its median value being $10.8 million (2023).
  • Per our database at Business Quant, Outset Medical's Current Deferred Revenue skyrocketed by 9806.31% in 2021 and then surged by 272.61% in 2025.
  • Over the past 5 years, Outset Medical's Current Deferred Revenue (Quarter) stood at $6.3 million in 2021, then skyrocketed by 36.62% to $8.7 million in 2022, then surged by 35.38% to $11.7 million in 2023, then rose by 8.75% to $12.8 million in 2024, then increased by 8.17% to $13.8 million in 2025.
  • Its Current Deferred Revenue was $13.8 million in Q4 2025, compared to $14.9 million in Q3 2025 and $14.0 million in Q2 2025.